Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Evaluating the Effectiveness of the Common Elements Treatment Approach (CETA) in Peru: Mechanisms of Individual and Intergenerational Change

19 juni 2026 bijgewerkt door: University of Notre Dame
Recent advances in intervention research have revealed the promise of transdiagnostic, modular approaches implemented by lay paraprofessionals for the treatment of the most prevalent mental health concerns in settings affected by adversity (e.g., anxiety, depression, posttraumatic stress), but to date, few effectiveness trials have examined the indirect effects of treatment on intergenerational and economic outcomes or moderators of treatment effectiveness. There is thus a critical need not only for the continued expansion of the evidence-basis for care in low-resource settings, but also for the evaluation of factors contributing to effectiveness across multiple dimensions to gain a better understanding of the sustainability, long-term benefits, and cost-effectiveness of these approaches. The current study will conduct a rigorous evaluation of an existing program, the Common Elements Treatment Approach (CETA) with women (N=300) who are mothers of young children (ages 4-6). The trial will take place in the context of an integrated community care setting in Lima, Peru's most populous and impoverished district, San Juan de Lurigancho. The primary aims are to (1) evaluate the primary and indirect effects of CETA (2) examine moderators of treatment effectiveness, including implementation quality and neighborhood factors and (3) examine CETA's cost effectiveness. The central hypotheses are that (H1a) CETA will improve women's mental health, intimate partner violence, and parenting and that (H1b) CETA will have indirect benefits for women's economic outcomes and for their children's adjustment. It is also hypothesized (H2) that effectiveness will be enhanced by strong implementation quality and the presence of neighborhood promotive factors, and weakened by neighborhood disadvantage. Hypotheses will be evaluated using an RCT employing a longitudinal design with assessments at baseline (T1), post-test (T2), 6-month follow-up (T3) and 12-month follow-up (T4). Women will be randomized into the intervention condition (CETA + Enhanced Case Management [ECM]) or the comparison condition (ECM). Robust, multi-source (i.e., participant, therapist, supervisor, census data) and multi-method data (i.e., interview, observational assessment, google street view coding) will be gathered. The contribution will be significant by advancing research on both direct and long-term benefits of maternal mental health care for family systems, and is likely to provide important insights into the sustainability and cost effectiveness of these approaches. The expected outcome is an evidence-based, cost-effective, integrated approach to maternal mental health care that can be readily implemented by local organizations. Further, it is anticipated that learnings from this project will respond to broader global public health concerns and provide opportunity for cross-context reciprocal innovation. Expanding the evaluation of CETA delivered in Spanish not only has advantages for the specific context under study, but provides an important foundation for addressing health disparities in Spanish-language mental health services in the US as well.

Studie Overzicht

Gedetailleerde beschrijving

The study will occur in the San Juan de Lurigancho district of Lima, Peru. Women who are mothers of children between the ages of 4 and 6 (N=300) will be recruited. Every effort will be made to recruit a diverse sample that reflects the demographics of the local community. Implementation of the project will be done through the Instituto de Pastoral de La Familia (INFAM), a community care organization offering a range of social services to families living in San Juan de Lurigancho district. Participants will be recruited from the community using direct referrals, self-referrals, and via informational flyers at local organizations.

Interested and potentially eligible women will contact the project coordinator, who will conduct an eligibility screen. In order to participate, women must: (1) live in San Juan de Lurigancho, Lima, Peru, (2) be at least 18 years of age, (3) have a child between the ages of 4 and 6, and (4) have the ability to travel to INFAM for study assessments and treatment sessions. Exclusion criteria include: (1) living outside of San Juan de Lurigancho, (2) those who are unable or unwilling to attend in-person sessions, or (3) the presence of severe intellectual disabilities or mental illness (these individuals will be referred to other local services). After confirming eligibility and interest, the most effective means of contacting the participant will also be established, including days and times in which calls can be accepted. Interested women will then be scheduled for a baseline interview, which will be conducted by trained research staff.

Enrollment will continue for approximately 1.75 years. The expected duration of the study for each participant will be approximately 14.5 months.

The primary aims of the of the proposed project are to: (1) evaluate the primary and indirect effects of CETA, (2) examine moderators of treatment effectiveness, including implementation quality and neighborhood factors, and (3) examine cost-effectiveness.

This objective will be evaluated in a randomized clinical trial with women (N=300) assigned to one of two conditions: Common Elements Treatment Approach + Enhanced Case Management (CETA + ECM) or ECM alone. Enhanced case management is considered the standard of care in this context. Women will be individually randomized at a 1:1 ratio across conditions.

CETA was specifically designed for implementation with lay paraprofessionals working in LMICs. It focuses on transdiagnostic approaches to addressing anxiety, posttraumatic stress, and depression. It also includes intervention elements related to IPV and caregiving CETA employs a flexible approach that is guided by the specific symptom presentation of the individual, thus balancing standardization and personalization - a key priority in global mental health. Components of CETA include the following modules: Engagement, Psychoeducation, Anxiety Management Strategies, Behavioral Activation, Cognitive Coping/Restructuring, Imaginal Gradual Exposure, In Vivo Exposure, Suicide/Homicide/Danger Assessment and Planning, and Screening/Brief Intervention for Alcohol. Recent work on CETA has also included a Caregiver Skills component, which aims to teach caregivers effective parenting skills, such as praise, selective attention, special time/positive attention, and behavior management. Depending upon client presentation, as informed by both baseline assessments and clinical presentation, CETA may range in length from 8-12, 1.5 hour sessions.

ECM will be provided to women in both conditions. ECM will include four stages: intake, referral, guided support, and follow-up. At intake, women will participate in a structured interview that includes a brief assessment of risk and protective factors in the following domains: social, economic, daily living, basic needs, and physical and mental health. Depending on assessed needs, women will be referred for relevant services either at INFAM or in the local community. As needed, the social worker will provide guided support for accessing services (e.g., coordinating with local clinics, helping with paperwork for insurance applications). Following this referral and support process, the social worker completes the social services support by conducting a follow-up interview to ascertain progress in accessing referrals and documents women's progress toward identified social service referral goals.

Baseline and post-test/follow-up questionnaires will each take approximately 2-2.5 hours, and will be administered at INFAM. Prior to beginning the baseline interviews, informed consent will be obtained in accord with current regulations enforced by local law and the institutional review board. During the informed consent process, participants will be informed of the purpose and general content of the program, and confidentiality guidelines and procedures will be reviewed. Interviewers will be trained employees of INFAM, all of whom will receive extensive training on clinical interview methods. They will be supervised by the project coordinator and by a local psychologist. Interviewers will complete a training co-designed by the PI, Co-Is and Consultants; standards of (1) the Notre Dame IRB, (2) standards for scientifically survey evaluation research, and (3) standards for clinical care at in the context of work with high-risk populations to gather sensitive information.

Primary outcome measures for the effectiveness evaluation will be Maternal Mental Health (Anxiety, Depression Posttraumatic Stress), IPV, and Parenting.

Studietype

Ingrijpend

Inschrijving (Geschat)

600

Fase

  • Fase 2

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

  • Naam: Laura Miller-Graff, PhD
  • Telefoonnummer: 574-631-3245
  • E-mail: lmiller8@nd.edu

Studie Locaties

      • Lima, Peru
        • Werving
        • Centro Patrizio Peyton
        • Contact:
          • Laura Miller-Graff, PhD
          • Telefoonnummer: 574-631-3245
          • E-mail: lmiller8@nd.edu

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Beschrijving

Inclusion Criteria:

  • live in San Juan de Lurigancho, Lima, Peru,
  • be at least 18 years of age,
  • have a child between the ages of 4 and 6, and
  • have the ability to travel to INFAM for study assessments and treatment sessions

Exclusion Criteria:

  • living outside of San Juan de Lurigancho,
  • those who are unable or unwilling to attend in-person sessions, or
  • the presence of severe intellectual disabilities or mental illness (these individuals will be referred to other local services)

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: CETA + Enhanced Case Management
Participants receiving CETA will receive a modular CBT 1-on-1 therapeutic program for approximately 12 weeks. They will also receive access to the standard of care provided by the partner agency (enhanced case management).
CETA was designed for implementation with lay paraprofessionals working in LMICs. It has shown evidence of effectiveness in addressing posttraumatic stress, depression, anxiety, IPV, substance use, and suicide/safety issues. CETA employs a precision science approach using a modular framework. That is, all participants receive a common core of elements (i.e., Engagement, Cognitive Coping/Restructuring, [and for this study] Caregiver Skills) with additional specific elements guided by individual symptom presentation, thus balancing standardization and personalization. Elements of CETA include: Engagement, Psychoeducation, Anxiety Management Strategies, Behavioral Activation, Cognitive Coping/Restructuring, Imaginal & Live Gradual Exposure, Suicide/Homicide/Danger Assessment and Planning, and Substance Use CBT/MI for Alcohol and Drug Use. The Caregiver Skills module includes information about effective parenting skills for preschool-aged children such as praise, selective
Andere namen:
  • CETA
Women assigned to both conditions will receive ECM, which is a standardized (already existing) service at INFAM that includes four stages: intake, referral, guided support, and follow-up. At intake, women will participate in a structured interview that includes a brief assessment of multisystem risk and protective factors (i.e., social, economic, daily living, basic needs, and physical and mental health). Depending on assessed needs, women will be referred to relevant services. As needed, the social worker will provide guided support for accessing services (e.g., helping with paperwork for insurance applications). The ECM process is concluded by a follow-up interview to ascertain progress in accessing referrals and documents women's progress toward identified social service referral goals across domains.
Actieve vergelijker: Enhanced Case Management
ECM will include a needs assessment and referral to needed resources, with a follow-up interview after approximately 12 weeks to see which resources were accessed.
Women assigned to both conditions will receive ECM, which is a standardized (already existing) service at INFAM that includes four stages: intake, referral, guided support, and follow-up. At intake, women will participate in a structured interview that includes a brief assessment of multisystem risk and protective factors (i.e., social, economic, daily living, basic needs, and physical and mental health). Depending on assessed needs, women will be referred to relevant services. As needed, the social worker will provide guided support for accessing services (e.g., helping with paperwork for insurance applications). The ECM process is concluded by a follow-up interview to ascertain progress in accessing referrals and documents women's progress toward identified social service referral goals across domains.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Depression
Tijdsspanne: Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Center for Epidemiological Studies Depression Scale: Scores from from 0 to 60, where low scores indicate better outcomes.
Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Posttraumatic Stress
Tijdsspanne: Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
PTSD Checklist for DSM-5: Scores range from 0 to 80, where lower scores indicate better outcomes.
Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Anxiety
Tijdsspanne: Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Generalized Anxiety Disorder - 7: Scores range from 0-21, with lower scores indicating better outcomes.
Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Wellbeing
Tijdsspanne: Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
WHO-5 Wellbeing Index: Scores range from 0-25 with higher scores indicating better outcomes.
Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Intimate Partner Violence
Tijdsspanne: Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Escala de Violencia; Scores range from 0-3, with lower scores indicating lower frequency of violence.
Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Parenting - observed
Tijdsspanne: Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Dyadic Parent Child Interaction Coding System: Scoring is a tally based system based on number of specific behaviors present; low scores indicate lower frequency of behavior and higher scores indicate higher frequency of behavior. Range floor is zero, with no set ceiling.
Baseline, 12-week post-test, 6-month follow-up, 12-month follow-up
Parenting - Self-reported
Tijdsspanne: Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up
Alabama Parenting Scale - Preschool Version: Positive parenting ranges from 0-48, inconsistent parenting from 0-28 and punitive parenting from 0-20. Higher scores indicate higher frequency of parenting behavior.
Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Child Adjustment
Tijdsspanne: Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up
Strengths and Difficulties Questionnaire; Total adjustment problems range from 0 to 40, with lower scores indicating lower levels of adjustment problems. Prosocial skills scores range from 0 to 10, with higher scores indicating better prosocial skills.
Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up
Emotion regulation & prosocial skills
Tijdsspanne: Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up
Social Competence Scale: Emotion regulation scores range from 0 to 24, with higher scores indicating better emotion regulation; prosocial skills range from 0 to 24, with higher scores indicating better prosocial skills.
Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up
Days out of work
Tijdsspanne: Baseline, 6-month follow-up, 12-month follow-up
Days spent out of work in the past month - range of 0 to 30
Baseline, 6-month follow-up, 12-month follow-up
Investment in children
Tijdsspanne: Baseline, 6-month follow-up, 12-month follow-up
Amount of money (in soles) invested in children in the past month. Floor of range is zero; no set ceiling.
Baseline, 6-month follow-up, 12-month follow-up
Time investment in children
Tijdsspanne: Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up
Amount of time spent doing activities with children: Range from 0 to 6, with higher values indicating more time spent with children.
Baseline, 12 week post-test, 6-month follow-up, 12-month follow-up
WHO Disability Index (selected items)
Tijdsspanne: Baseline, 6-month follow-up, 12-month follow-up
6 items evaluating difficulties with concentration, work and health impacts: Range 0-24 with lower scores indicating better outcomes.
Baseline, 6-month follow-up, 12-month follow-up
Decisions in the home
Tijdsspanne: Baseline, 6-month follow-up, 12-month follow-up
6 items maternal role in decision making on a variety of topics; responses are categorical by decision maker (i.e., you, your partner, you and your partner together, someone else, you with someone else, N/A)
Baseline, 6-month follow-up, 12-month follow-up

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

18 mei 2026

Primaire voltooiing (Geschat)

30 april 2030

Studie voltooiing (Geschat)

30 april 2030

Studieregistratiedata

Eerst ingediend

5 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

19 juni 2026

Eerst geplaatst (Werkelijk)

25 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

25 juni 2026

Laatste update ingediend die voldeed aan QC-criteria

19 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 25-09-9575
  • R01HD116815 (Subsidie/contract van de Amerikaanse NIH)

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

De-identified data will be shared at the conclusion of the study.

IPD-tijdsbestek voor delen

Code an analytic plan will be made available as a part of publications; study protocol will be published open access during the study

IPD-toegangscriteria voor delen

All study data will be open access with the exception of raw data, which is available by reasonable request.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren